littl
known
tcell
immun
sever
acut
respiratori
syndrom
sar
coronaviru
two
sar
patient
examin
memori
tcell
respons
peptid
deriv
sar
coronaviru
structur
protein
gener
tcell
line
peptid
spike
protein
defin
hla
restrict
one
patient
predomin
memori
tcell
respons
direct
epitop
outsid
protein
receptorbind
domain
patient
frequenc
memori
tcell
viru
structur
protein
antisar
coronaviru
igg
level
low
month
infect
report
expand
understand
specif
durat
antisar
coronaviru
tcell
immun
respons
sever
acut
respiratori
syndrom
sar
caus
sar
coronaviru
sar
cov
emerg
zoonot
origin
late
southern
china
drosten
et
al
humantohuman
transmiss
spread
sar
countri
epidem
end
juli
produc
case
overal
casefat
rate
reemerg
sar
cov
transmiss
human
like
remain
possibl
potenti
zoonot
coronavirus
jump
human
caus
seriou
ill
also
exist
ideal
vaccin
candid
sar
sarslik
coronavirus
induc
robust
humor
cellmedi
immun
respons
neutral
antibodi
sar
cov
direct
epitop
viru
spike
structur
protein
antibodi
elicit
protect
immun
anim
model
sar
greenough
et
al
robert
et
al
subbarao
et
al
less
known
tcell
immun
sar
cov
infect
particularli
thelper
immun
could
promot
protect
antibodi
develop
undertook
studi
character
tcell
respons
direct
structur
protein
sar
cov
two
healthcar
worker
recov
sar
approach
first
identifi
peptid
stimul
interferon
ifn
respons
memori
tcell
unbias
fashion
possibl
gener
character
tcell
line
peptid
measur
circul
frequenc
peptidespecif
memori
tcell
month
infect
peptid
pool
screen
peripher
blood
mononuclear
cell
elispot
peripher
blood
mononuclear
cell
pbmc
collect
month
sar
cov
infect
stimul
elispot
assay
overlap
peptid
pool
span
sar
cov
structur
protein
envelop
e
matrix
nucleocapsid
n
protein
peptidespool
peptid
concentr
pbmc
one
recov
sar
patient
sar
patient
peptid
pool
produc
spotform
cell
singh
raghava
rammense
et
al
memori
tcell
direct
peptid
pool
detect
intracellular
cytokin
stain
ic
two
round
vitro
restimul
expans
individu
peptid
concentr
tcell
sar
patient
sar
seroneg
control
sinc
sar
patient
measur
memori
tcell
respons
ex
vivo
stimul
patient
pbmc
differ
individu
peptid
taken
posit
pool
elispot
assay
peptid
concentr
select
five
peptid
highest
sfc
frequenc
rang
pbmc
studi
five
peptid
viral
protein
five
proteinderiv
peptid
pool
use
bulk
cultur
stimul
convalesc
pbmc
sar
patient
tcell
line
direct
peptid
success
establish
tabl
four
tcell
line
recogn
peptid
tecanlllqygsfctql
line
clearli
hladrrestrict
ctl
activ
allogen
target
cell
suggest
restrict
optim
epitop
restrict
tcell
activ
essenti
entir
peptid
ic
peptid
h
peptid
flank
overlap
peptid
stimul
product
four
tcell
line
note
fig
highest
gene
frequenc
report
latino
american
asian
american
racial
group
allel
report
moder
frequenc
filipino
popul
mack
et
al
peptid
stffstfkcygvsatkl
also
appear
restrict
hla
restrict
peptid
nidatstgnynykyrylr
unabl
determin
tabl
neutral
antibodi
sar
cov
recogn
epitop
receptorbind
domain
rbd
proteinbetween
amino
acid
et
al
hwang
et
al
li
et
al
two
three
protein
tcell
epitop
identifi
rbd
howev
predomin
tcell
respons
recov
sar
patient
direct
epitop
outsid
rbd
frequenc
sfc
peptid
greatest
month
sar
cov
infect
patient
decreas
near
limit
detect
elispot
month
onward
pbmc
fig
specif
ctl
activ
could
still
detect
vitro
restimul
sar
patient
pbmc
collect
month
specif
lysi
month
wane
specif
memori
tcell
parallel
wane
antisar
cov
igg
level
sar
patient
antisar
cov
igg
level
alreadi
lower
patient
patient
month
fig
antisar
cov
igg
memori
tcell
respons
weaker
wane
rapidli
patient
compar
patient
cell
line
surfacestain
monoclon
antibodi
mab
analyz
flow
cytomet
bd
bioscienc
san
jose
ca
valu
lymphocyt
also
b
cell
line
stimul
specifi
peptid
ic
assay
result
whether
cell
cell
line
nd
done
c
hla
restrict
determin
inhibit
cytotox
activ
standard
cr
releas
ctl
assay
presenc
block
mab
hla
haplotyp
compar
isotyp
control
mab
nd
done
specif
memori
tcell
frequenc
sar
patient
measur
elispot
ic
notabl
higher
sar
patient
seroneg
close
contact
includ
fig
epitopespecif
tcell
frequenc
month
infect
approxim
lower
report
month
natur
influenza
viru
infect
adult
linnemann
et
al
influenza
sar
respiratori
viru
infect
tcell
respons
influenza
adult
secondari
one
compar
primari
tcell
respons
sar
even
though
gener
tcell
line
peptid
patient
pbmc
direct
ex
vivo
circul
frequenc
memori
tcell
peptid
low
near
limit
detect
elispot
month
infect
pbmc
low
specif
memori
tcell
frequenc
sar
patient
differ
sar
patient
seroneg
close
contact
fig
tcell
respons
peptid
weaker
decreas
rapidli
tcell
respons
sar
patient
tcell
respons
sar
cov
structur
protein
epitop
weaker
decreas
rapidli
sar
patient
compar
patient
howev
result
determin
level
peptidespecif
memori
tcell
antisar
cov
igg
associ
effect
sar
cov
immun
one
group
measur
sar
covspecif
memori
tcell
respons
recov
sar
individu
peng
et
al
b
yang
et
al
individu
tcell
epitop
identifi
within
n
protein
peng
et
al
believ
studi
first
identifi
individu
human
tcell
epitop
within
sar
cov
protein
character
hla
restrict
also
identifi
potenti
peptid
sar
cov
e
protein
suggest
sar
cov
protein
rbd
could
effect
subunit
vaccin
et
al
find
suggest
domin
sar
cov
anti
thelper
respons
could
direct
epitop
outsid
rbd
data
also
illustr
individu
humor
tcell
immun
sar
cov
may
wane
rapidli
level
humor
tcell
immun
associ
clinic
protect
remain
unknown
improv
understand
sar
covspecif
memori
immun
respons
help
guid
futur
vaccin
strategi
event
sar
sarslik
coronaviru
reemerg
human
limit
outbreak
sar
occur
philippin
april
april
collect
serial
convalesc
blood
sampl
two
healthcar
worker
contract
sar
outbreak
recov
healthi
contact
peripher
blood
mononuclear
cell
pbmc
plasma
aliquot
cryopreserv
red
blood
cell
rbc
pellet
contain
granulocyt
use
hla
type
biotest
abdr
ssp
kit
biotest
diagnost
corp
denvil
nj
particip
provid
written
inform
consent
protocol
approv
institut
review
board
univers
massachusett
medic
school
research
institut
tropic
medicin
total
peptid
span
sar
cov
envelop
matrix
nucleocapsid
spike
protein
provid
nih
niaid
beiresourc
repositori
cat
peptid
amino
acid
length
overlap
amino
acid
assay
elispot
assay
perform
previous
describ
without
addit
costimulatori
antibodi
jameson
et
al
tcell
line
establish
bulk
cultur
peptid
stimul
limit
dilut
standard
cr
releas
ctl
assay
jameson
et
al
ic
assay
perform
stimul
peptid
presenc
golgi
inhibitor
brefeldin
previous
describ
mangada
et
al
antisar
cov
igg
titer
measur
elisa
inactiv
virusinfect
cell
lysat
serial
plasma
sampl
previous
describ
ksiazek
et
al
fourfold
serial
dilut
plasma
elispot
assay
peptid
concentr
result
express
number
peptidespecif
spotform
cell
sfc
pbmc
media
background
subtract
mean
triplic
valu
b
antisar
cov
igg
titer
measur
elisa
inactiv
virusinfect
cell
lysat
serial
plasma
sampl
collect
sar
patient
fourfold
serial
dilut
plasma
sampl
assay
duplic
reciproc
titer
undetect
code
reciproc
titer
c
pbmc
collect
month
sar
outbreak
two
sar
patient
sar
seroneg
healthi
contact
stimul
peptid
elispot
assay
peptid
concentr
two
healthi
contact
result
express
number
peptidespecif
pbmc
media
background
subtract
mean
triplic
valu
sampl
assay
duplic
reciproc
titer
b
undetect
code
reciproc
titer
healthi
contact
undetect
antisar
cov
igg
level
reciproc
titer
b
